Skip to main content
CU MEDICAL SYSTEMS Inc. logo

CU MEDICAL SYSTEMS Inc. — Investor Relations & Filings

Ticker · 115480 ISIN · KR7115480006 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2026-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 115480

About CU MEDICAL SYSTEMS Inc.

https://cu-europe.com/

CU MEDICAL SYSTEMS Inc. is a medical device manufacturer specializing in defibrillators and resuscitation products. The company develops and distributes a comprehensive range of devices, from Automated External Defibrillators (AEDs) for public access to advanced defibrillator/monitors for hospital settings. A key offering is the iPAD-Link System, a smart remote management solution that enables 24/7 monitoring of AED status, including location, battery levels, and pad condition, to ensure operational readiness. The company was a pioneer in the independent development of AED technology and continues to innovate with systems that combine cardiopulmonary resuscitation (CPR) and defibrillation features.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for CU Medical Systems. It contains the agenda for the 25th Annual General Meeting, including the approval of financial statements, changes to the articles of incorporation, and director compensation. While it includes financial data (balance sheets, income statements) as part of the meeting materials, the primary purpose of the document is to notify shareholders of the upcoming meeting and provide the necessary information for voting. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-11 Korean
[기재정정]임원ㆍ주요주주특정증권등거래계획보고서
Regulatory Filings Classification · 95% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). It details a correction to a previously submitted trading plan regarding the sale of shares by a major shareholder (X-Cure Co., Ltd.). This type of filing is a regulatory requirement for insiders/major shareholders to disclose their intent to trade company securities. Since it does not fit into the specific categories of 'Director's Dealing' (which usually refers to completed trades) or 'Major Shareholding Notification' (which refers to crossing thresholds), it is best classified as a Regulatory Filing (RNS) as it is a formal regulatory disclosure document.
2026-03-11 Korean
주식등의대량보유상황보고서(약식)
Regulatory Filings Classification · 95% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by a specific entity (Xcure Corp.) in a target company (CU Medical Systems). This type of filing is used to notify the market and regulators of significant changes in shareholding levels. Since it does not fit into specific categories like 'Director's Dealing' (which is for individual insiders) or 'M&A Activity', and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2026-03-03 Korean
주식병합결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding a 'Stock Consolidation' (주식병합결정) by the company CU Medical. It details the change in par value, the reduction in the total number of shares, the timeline for the consolidation, and the purpose (stock price stabilization). This falls under capital structure changes, which is classified as 'Share Issue/Capital Change' (SHA).
2026-02-27 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by CU Medical. It outlines the date, location, and agenda items (such as financial statement approval, articles of incorporation changes, and director compensation limits) for the upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2026-02-27 Korean
[기재정정]임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 98% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주특정증권등거래계획보고서) filed with the Korean financial authorities. This document details the planned sale of shares by a major shareholder (X-Cure Co., Ltd.) in CU Medical Systems. In the context of the provided categories, this relates to insider trading plans and share transactions by major stakeholders. Since it specifically details the planned disposal of shares by a major shareholder, it falls under the category of 'Director's Dealing' (DIRS), which covers insider share transactions and related reporting requirements.
2026-02-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.